non small cell lung - Globe Thesis

Keyword [non small cell lung] Result: 161 - 180 \| Page: 9 of 10
161.	Expression Of 14-3-3zeta And Its Influence On Tumor Development And Apoptosis In Stage T₁ Non-small Cell Lung Cancer
162.	Expression And Clinical Significance Of Survivin,P53 And Bcl-2 In ⅢA Non-small Cell Lung Cancer(NSCLC)before And After Neoadjuvant Chemotherapy
163.	The Mechanism Of Gefitinib Resistance Induced By Hepatocyte Growth Factor In Sensitive Non-small Lung Cancer Cells
164.	Hepatocellular Careinoma HepG2 Therapy Mediated By Tumor Suppressor Of Non-small Cell Lung Cancer 1
165.	Effect Of NKTm Cells Plus Cisplatin/cetuximab Treatment On NSCLC Cells In Vitro
166.	Concurrent Chemoradiotherapy For Locally Advanced Non-small Cell Lung Cancer Clinical Outcomes Of Patients With Malignant Lung Lesions Treated With Stereotactic Body Radiation Therapy
167.	Expression Of Nm23 And E-cadherin In Stage Ⅰ Non-small Cell Lung Cancer, And Their Relationship With Lymph Node Micrometastasis And Prognosis
168.	Anti-tumor Activity Of Fucoxanthin, An Active Ingredient Of Kelp Extract, Against Human NSCLC And Its Mechanism
169.	Detection And Identification Of Serum Biomarkers Of Non-small Cell Lung Cancer
170.	Research Of Health Technology Assessment For PET-CT In The Diagnosis Of Non-small Cell Lung Cancer
171.	The Efficacy Prediction Of Tyrosine Kinase Inhibitor For Treatment Of Advanced Non-small Cell Lung Cancer And The Related Basic Research
172.	The Changes Of CD4~+CD25~+ Regulatory T Cells Of Non Small-cell Lung Cancer Patients And The Effects Of CpG ODN
173.	Anti-Paclitaxel Resistance Effect Of Somatostatin Receptors Mediated Targeted Therapy On Non-small Cell Lung Cancer Cells And Its Possible Mechanisms
174.	Functional Imaging And Proteomics Techniques Predict Sensitivity To Chemoradiotherapy In Non-Small Cell Lung Cancer
175.	Combined Epidermal Growth Factor Receptor Targeting With The Tyrosine Kinase Inhibitor And The Monoclonal Antibody In No-Small Cell Lung Cancer
176.	Effects And Mechanisms Of Combined Treatment With Everolimus And Gefitinib On Non-small Cell Lung Cancer Cell Lines
177.	Clinical Relevance And Underlying Mechanism Of Altered Expression Of Proto-oncogene BCL11A In Non-small Cell Lung Cancer
178.	The Antitumor Activity Of A Novel Dual PI3Kα/mTOR Inhibitor PI-103 In Cancer Therapy
179.	Anticancer Activity And Mechanism Of Natural And Target-designed Small Molecule Compounds On Non-small Cell Lung Cancer
180.	Study On Human Non-small Cell Lung Cancer-related Free Proteins
<<First <Prev Next> Last>> Jump to